期刊文献+

前列腺癌包膜侵犯预测模型的建立 被引量:1

Establishment of regression model predicting the probability of the capsular penetration of prostate cancer
原文传递
导出
摘要 目的 建立基于中国人样本资料的回归模型,根据术前临床指标预测前列腺癌包膜侵犯的发生概率.方法 回顾性分析2006年1月至2010年4月在我院接受前列腺癌根治术患者的资料.根据术后病理是否出现包膜侵犯分为器官局限组与局部晚期组并排除区域淋巴结发生转移的病例.收集两组病例的前列腺特异性抗原检测值、Gleason分级、临床分期等资料.根据术前临床指标及术后病理建立多重Logistic回归模型来预测前列腺癌包膜侵犯的发生率.利用受试者工作特征曲线评估模型的准确性.结果 器官局限组83例,年龄(66.8±5.8)岁,局部晚期组36例,年龄(66.0±6.8),两组间年龄的差异无统计学意义(t=0.650,P=0.517).局部晚期组前列腺特异性抗原检测值较高(Wilcoxon W=4562.0,P=0.016),Gleason分级也较高(Wilcoxon W=4586.5,P=0.016),临床分期较晚(Wilcoxon W=4444.5,P=0.001),差异均具有统计学意义.多重Logistic回归模型判别公式为Logit P=0.488×Gleason分级+0.104×临床分期-6.187.该模型自由度为2,似然比卡方检验χ2=11.263,P=0.004.利用本模型预测本组病例术后包膜侵犯概率的受试者工作特征曲线下面积为0.696,其95%置信区间为0.598~0.793,P=0.001.结论 基于中国前列腺癌人群资料建立的多重Logistic回归模型可以较为准确地预测包膜侵犯的发生概率,具有较高的内部准确性,可供临床决策时参考. Objective To establish the regression model predicting the probability of the capsular penetration according to the Chinese prostate cancer samples. Methods Men enrolled in the Fudan University Shanghai Cancer Centre and undergoing radical prostatectomy between January 2006 and April 2010 were used to establish the predicting model. According to the pathology after radical prostatectomy, all cases were divided into two groups: organ confined disease group and locally advanced disease group, the difference of which were whether had the capsular penetration. The cases with regional lymph node metastasis were excluded. Serum prostate specific antigen level, Gleason grade, clinical stage were collected. Multiple Logistic regression model was established according to preoperative clinical data and postoperative pathological data to predict the incidence of capsular penetration. Receiver operating characteristic curve was used for the internal validation of the model. Results 83 Chinese men were identified in the organ confined disease group with the age of 66. 8 ± 5.8 years, and 36 in the locally advanced disease group with the age of 66. 0 ± 6. 8 years. The difference of the age between the two groups were of no statistic significance(t = 0. 650, P = 0. 517). The serum prostate specific antigen level (Wilcoxon W =4562.0, P =0. 016), Gleason score(Wilcoxon W =4586. 5, P =0. 016), and clinical stage (Wilcoxon W= 4444. 5, P= 0. 001) of the locally advanced disease group were higher than the other group. The equation of the multiple Logistic regression model was Logit P = 0. 488 × Gleason score + 0. 104 × clinical stage - 6. 187, with the freedom degree of two and the likelihood ratio χ2 test of 11. 263 (P= 0. 001) . The area under the ROC curve (AUC) for capsular penetration was 0.696 (P=0.001), with the 95% onfidence interval of 0.598-0.793. Conclusion The multiple Logistic regression model based on the Chinese. population can accurately predict the probability of capsular penetration of the prostate cancer and work on well with high internal accuracy when clinical decisions are made.
出处 《中华医学杂志》 CAS CSCD 北大核心 2010年第42期2976-2979,共4页 National Medical Journal of China
关键词 前列腺肿瘤 肿瘤侵润 人体模型 Prostate neoplasm Neoplasm invasiveness Manikins
  • 相关文献

参考文献14

  • 1李康,林一帆.评价判别模型诊断效果的ROC分析[J].中国卫生统计,1996,13(3):9-12. 被引量:22
  • 2Hull GW,Rabbani F,Abbas F,et al.Cancer control with radical prostatectomy alone in 1000 consecutive patients.J Urol,2002,167:528-534.
  • 3Graefen M,Haese A,Pichlmeier U,et al.A validated strategy for side specific prediction of organ confined prostate cancer:a tool to select for nerve sparing radical prostatectomy.J Urol,2001,165:857-863.
  • 4Stamey TA,Caldwell M,McNeal JE,et al.The prostate specific antigen era in the United States is over for prostate cancer:what happened in the last 20 years? J Urol,2004,172:1297-1301.
  • 5林宁殊,夏溟.前列腺癌根治术后生化复发危险因素及预测研究进展[J].中华医学杂志,2009,89(24):1721-1723. 被引量:3
  • 6D'Amico AV,Whittington R,Malkowicz SB,et al.The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer.J Urol,1998,160:2096-2101.
  • 7Partin AW,Kattan MW,Subong EN,et al.Combination of prostate-specific antigen,clinical stage,and Gleason score to predict pathological stage of localized prostate cancer.A multiinstitutional update.Jama,1997,277:1445-1451.
  • 8Kattan MW,Eastham JA,Stapleton AM,et al.A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.J Natl Cancer Inst,1998,90:766-771.
  • 9Kattan MW,Zelefsky MJ,Kupelian PA,et al.Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer.J Clin Oncol,2000,18:3352-3359.
  • 10Partin AW,Mangold LA,Lamm DM,et al.Contemporary.update of prostate cancer staging nomograms (Partin Tables) for the new millennium.Urology,2001,58:843-848.

二级参考文献71

  • 1李康,郭祖超,胡琳,徐勇勇.有序分类数据的累积比数模型分析方法[J].中国卫生统计,1993,10(4):35-38. 被引量:18
  • 2李康,林一帆.评价判别模型诊断效果的ROC分析[J].中国卫生统计,1996,13(3):9-12. 被引量:22
  • 3Partin AW, Yoo J, Carter HB, et aI. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol, 1993, 150:110-114.
  • 4Narayan P, Gajendran V, Taylor SP, et al. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate specific antigen and biopsy Gleason score in prediction of final pathological diagnosis in prostate cancer. Urology, 1995, 46 : 205-212.
  • 5Partin AW, Kattan MW, Subong EN, et al. Combination of prostate specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA,1997, 227 : 1445-1451.
  • 6Partin AW, Mangold LA, Lamrn DM, et al. Contemporary update of prostate cancer staging nomograms(Partin tables) for the new millennium. Urology, 2001, 58:843-848.
  • 7Makarov DV, Trock BJ, Humphreys EB, et al. Updated nomogram to predict pathological stage of prostate cancer given prostate specific antigen level, clinical stage, and biopsy Gleason score(Partin tables) based on cases from 2000 to 2005. Urology, 2007, 69: 1095-1101.
  • 8Blute ML, Bergstralh EJ, Partin AW, et al. Validation of Partin tables for predicting pathological stage of clinically to calized prostate cancer. J Urol, 2000, 164:1591-1595.
  • 9Person DF, Grossfeld GD, Li YP, et al. How well does the Partin nomogram predict pathological stage after radical pros tatectomy in a community-based population? Results of the cancer of the prostate strategic urological research endeavor. J Urol, 2002, 167: 1653-1658.
  • 10Graefen M, Augustin H, Karakiweicz PI, et al. Can predictive models for prostate cancer patients derived in the USA be utilized in European patients? A validation study of the Partin tables. Eur Urol, 2003, 43:6-11.

共引文献43

同被引文献3

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部